%0 Journal Article
%T Gemcitabine in Bone Sarcoma Resistant to Doxorubicin-Based Chemotherapy
%A Ofer Merimsky
%A Isaac Meller
%A Yehuda Kollender
%A Josephine Issakov
%A Gideon Flusser
%A Moshe Inbar
%J Sarcoma
%D 2000
%I Hindawi Publishing Corporation
%R 10.1155/s1357714x00000025
%X Subjects and Methods: Seven patients with progressive localized or metastatic chemo-resistant osteosarcoma were treated by gemcitabine.The protocol included gemcitabine 1000 mg/m2/w for 7 consecutive weeks, followed by 1 week rest. If no progression was observed,maintenance by gemcitabine 1000 mg/m2/w for 3 weeks every 28 days was given until failure was clinically or radiologically evident.
%U http://www.hindawi.com/journals/srcm/2000/819125/abs/